Ignite Creation Date:
2024-05-05 @ 9:53 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000298
Status:
COMPLETED
Last Update Posted:
2005-08-17
First Post:
1999-09-20
Brief Title:
Buprenorphine Combination Tablet Feasibility - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Organization Data
Organization:
National Institute on Drug Abuse NIDA
Class:
NIH
Study ID:
NIDA-09260-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institute on Drug Abuse NIDA
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None